FINANCEMARKETS.INFO
European markets opened higher on August 6, 2026, as strong German factory orders supported the DAX and BEL 20, while Rheinmetall fell after cutting its sales outlook.
Bimzelx generated €1.52 billion in the first half of 2026. Could UCB’s flagship immunology medicine eventually be worth more than €20 billion?
AB InBev has now delivered two consecutive quarters of beer-volume growth, supported by Latin America and strong demand for Corona, Stella Artois and Michelob […]
The BEL 20 is up almost 14% in 2026. We examine its valuation, dividend yield, concentration, largest stocks and performance against the STOXX 600.
Brussels outperformed European markets as the BEL 20 gained 1.21%. UCB and AB InBev advanced, while Novo Nordisk and HSBC declined.
Swiss cloud provider Infomaniak is preparing an unconventional entry onto the SIX Swiss Exchange, while Belgium waits for a genuine revival of IPO activity. […]
European equities remained firmly higher at noon on Wednesday, supported by industrial, technology and mining shares. The BEL 20 outperformed most regional benchmarks, with […]
The BEL 20 gained around 1% on August 4, 2026, as Umicore, Elia, Melexis and UCB led a broad rally on the Brussels stock exchange.
